🔗 Share this article

An underground economy for unlicensed weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Investigational Drug Gaining Traction Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are urged to message these profiles privately for supplier links, while also obtaining discount codes.

Active Commerce on Messaging Platforms

Additionally, a robust market exists on messaging services, where groups with numerous of participants share comparison photos, administration instructions and claims of next-day UK delivery. Sellers promote the drug there before directing buyers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Experts Express Concerns

Nevertheless, physicians and pharmacists have cautions that the sale of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to individuals administering products of unknown origin.

Several professionals stated the popularity for retatrutide could be connected to the rising price of approved weight loss products such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach pharmaceutical, marketing, and consumer laws, risking penalties, prosecution or prison.

Service Reaction and Content Removal

According to the social media company, the service has removed violative material and banned associated hashtags and query recommendations. The company stated it was dedicated to maintaining the service safe and investing in strengthening compliance measures.

Online Marketplace Activities

Research also found communities with up to 9,000 members selling retatrutide using Telegram's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up channels with numerous of users, filled with photos of weight loss, glowing reviews and detailed instructions for mixing or administering at residence.

Within minutes of joining one community, a vendor shared contact information, where the majority of purchases take place. The seller provided an guidebook and guaranteed shipping within two days. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about body mass, medical conditions or previous experience.

Product Information and Pricing

Within these communities, messages display black plastic parcels with postal service labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with purified liquid, or pre-filled pens typically sold at £160 for 20 milligrams. When questioned how long a pen should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Service Moderation and Security Measures

A representative for Telegram stated it actively monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering materials they can’t verify. Although the research behind retatrutide is valid, these online products may not contain what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in interest to current price rises for approved slimming drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained.

Her staff has previously encountered patients harmed by self-injection from unverified sources. “We understand the disappointment, but buying from Telegram or communication platforms is taking chances with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company investigational product not yet approved … may expose users to potentially serious medical dangers”.